Bevacizumab for the treatment of high-grade glioma: an update after Phase III trials

By Khasraw Mustafa   Ameratunga Malaka   Grommes Christian  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

Convection-enhanced delivery of ¹³¹I-chTNT-1/B mAB for treatment of high-grade adult gliomas

By Hdeib Alia   Sloan Andrew E  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 799-806

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in the treatment of colorectal cancer

By Mulcahy Mary F   Benson III Al B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 7, 2005-07 ,pp. : 997-1005

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia

By Kanellopoulou Theoni  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1315-1323

Informa Healthcare

Access to resources Recommend Favorite

Molecular cytogenetic analysis of a novel high-grade canine T-lymphoblastic lymphoma demonstrating co-expression of CD3 and CD79a cell markers

By Thomas Rachael   Smith Ken   Gould Rob   Gower Sue   Binns Matthew   Breen Matthew  

Chromosome Research, Vol. 9, Iss. 8, 2001-12 ,pp. : 649-657

Springer Publishing Company

Access to resources Recommend Favorite